Literature DB >> 9352289

Executive control and the comprehension of medical information by elderly retirees.

D R Royall1, J Cordes, M Polk.   

Abstract

This study examined the independent contributions of executive control function, general cognition, age, education, and medication usage to the comprehension of medical information. Randomly selected elderly retirees (N = 105) more than 70 years of age completed the Executive Interview (EXIT25), the Mini-Mental State Exam (MMSE), and the Hopkins Competency Assessment Test (HCAT). Cognitive measures were stronger predictors of HCAT scores than age, education, or number of prescribed medications. A discriminant model based on EXIT25 and MMSE scores correctly classified 91% of subjects relative to their HCAT scores. It was concluded that executive impairment is strongly associated with impaired comprehension of medical information. As many as 88% of probable Alzheimer's disease patients, 69% of institutionalized elderly retirees, and 49% of noninstitutionalized retirees may be impaired in their ability to comprehend medical information, even when it has been presented well below their educational level.

Entities:  

Mesh:

Year:  1997        PMID: 9352289     DOI: 10.1080/03610739708254033

Source DB:  PubMed          Journal:  Exp Aging Res        ISSN: 0361-073X            Impact factor:   1.645


  12 in total

1.  Executive dyscontrol in normal aging: normative data, factor structure, and clinical correlates.

Authors:  Donald R Royall; Laura K Chiodo; Marsha J Polk
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  The rural older adult memory (ROAM) study: a practice-based intervention to improve dementia screening and diagnosis.

Authors:  Linda Boise; Elizabeth Eckstrom; Lyle Fagnan; Anne King; Monica Goubaud; David I Buckley; Cynthia Morris
Journal:  J Am Board Fam Med       Date:  2010 Jul-Aug       Impact factor: 2.657

3.  Conception of medical prescription in the elderly.

Authors:  E Monfort; P Allain; G Berrut; D Le Gall
Journal:  J Nutr Health Aging       Date:  2008-04       Impact factor: 4.075

4.  Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia.

Authors:  Jennifer Moye; Michele J Karel; Ronald J Gurrera; Armin R Azar
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

5.  Biomarkers for cognitive aging part II: oxidative stress, cognitive assessments, and medication adherence.

Authors:  Kathleen C Insel; Ida M Moore; Amy N Vidrine; David W Montgomery
Journal:  Biol Res Nurs       Date:  2011-05-17       Impact factor: 2.522

Review 6.  The doctor's duty to the elderly patient in clinical trials.

Authors:  Antony Bayer; Mark Fish
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Patient autonomy for the management of chronic conditions: a two-component re-conceptualization.

Authors:  Aanand D Naik; Carmel B Dyer; Mark E Kunik; Laurence B McCullough
Journal:  Am J Bioeth       Date:  2009-02       Impact factor: 11.229

8.  A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: relationship to blood pressure and other cardiovascular risks.

Authors:  Ihab Hajjar; Frances Yang; Farzaneh Sorond; Richard N Jones; William Milberg; L Adrienne Cupples; Lewis A Lipsitz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-17       Impact factor: 6.053

9.  Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior.

Authors:  Soo Borson; James Scanlan; Jeffrey Hummel; Kathy Gibbs; Mary Lessig; Elizabeth Zuhr
Journal:  J Gen Intern Med       Date:  2007-04-20       Impact factor: 5.128

10.  The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.

Authors:  Ihab Hajjar; Meaghan Hart; William Milberg; Vera Novak; Lewis Lipsitz
Journal:  BMC Geriatr       Date:  2009-11-18       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.